TYK Medicines-B (02410) has announced that its Chairman, Executive Director and President, Dr. Wu Yusheng, has informed the company of his recent share purchases in the open market. Dr. Wu may continue to acquire shares based on market conditions, with the total expected increase not exceeding HK$2 million.

Dr. Wu has committed to the company that any shares acquired through this increase over the next month will be voluntarily locked up for six months from the respective purchase dates. During the lock-up period, he will not sell or otherwise transfer these shares.

Dr. Wu stated that the funds for this share purchase come from his own resources. This move underscores his strong belief and full confidence in the future growth prospects of the group.